Newsletter: January 2021
Gynuity is at the forefront of efforts to develop the concept of missed period pills in the United States. Missed period pills involve use of uterine evacuation medications for treatment of delayed menses without prior pregnancy confirmation. In September, Gynuity published findings from a study of potential interest in such a product in two US states. We enrolled 678 people seeking pregnancy tests across nine health centers. In all, 42% of participants expressed interest in missed period pills, and interest was greatest (70%) among those who would be unhappy if pregnant. Our findings suggest that if missed period pills were an option in the United States, demand might be substantial.